Providing Cure Through Innovative Technology With Mark Gergen of Poseida
Mar 08, 2022•25 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Listen on Apple, Google, Spotify, and other platforms.
- Introducing Mark [02:00]
- Mark provides an overview of what Poseida is [02:20]
- Mark shares how he ended up in life sciences and how it led him to San Diego [04:04]
- What San Diego and the biotech industry were like when Mark moved to the city [07:14]
- The founding story of Poseida and what the company is currently working on [08:40]
- Mark shares the development of CAR-T [10:33]
- An update on the technology, the current programs in Poseida’s clinic and trial dates [12:39]
- Mark talks about Poseida going public during the pandemic, and how it started [14:55]
- How the pandemic affected the world of biotech IPO [16:56]
- What makes working in biotech rewarding [17:25]
- Mark shares details about Poseida’s first strategic collaboration with Takeda Pharmaceutical [18:27]
- Mark shares what the biotech community is like during a pandemic and what war talent is [19:59]
- Mark’s favorite taco spot, Not Not Tacos, and Yesenia’s [22:30]
Follow Mark online
For the best experience, listen in Metacast app for iOS or Android